Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 10Unknown 6Terminated 2Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 1Liver Neoplasms 1Aortic Aneurysm 1Advanced Gastric Carcinoma 1

Interventions

pembrolizumab 563Specimen Handling 493Carboplatin 451Magnetic Resonance Spectroscopy 444Cyclophosphamide 418Cisplatin 405Radiotherapy 353Bevacizumab 314Gemcitabine 313Paclitaxel 298Biopsy 292Drug Therapy 284Blood Specimen Collection 248Capecitabine 246Oxaliplatin 241fludarabine 239Nivolumab 234venetoclax 221Injections 213Docetaxel 211Fluorouracil 206Dexamethasone 188Radiosurgery 182Standard of Care 159Rituximab 159Pemetrexed 156Surgical Procedures, Operative 148atezolizumab 146durvalumab 145Leucovorin 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × ferric carboxymaltose × Clear all
NCT05226169 2026-04-03

Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)

Asan Medical Center

Phase 3 Recruiting
330 enrolled
Gastrointestinal

Advanced Gastric Carcinoma

NCT05744219 2024-10-21

IRIS

Uppsala University Hospital

Phase 3 Recruiting
338 enrolled
Gastrointestinal

Aortic Aneurysm, Liver Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡